Paper41003755
Development of a Genetically Modified Lactococcus lactis Strain that Produces a Single-Chain Variable Fragment Targeting Interleukin-6 Receptor α to Suppress Serum Amyloid A.
Yoda M and 9 others. Curr Microbiol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development of a Genetically Modified Lactococcus lactis Strain that Produces a Single-Chain Variable Fragment Targeting Interleukin-6 Receptor α to Suppress Serum Amyloid A. Papers, record 41003755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003755
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a Genetically Modified Lactococcus lactis Strain that Produces a Single-Chain Variable Fragment Targeting Interleukin-6 Receptor α to Suppress Serum Amyloid A.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lactococcus lactis | Major topic |
| Single-Chain Antibodies | Major topic |
| Receptors, Interleukin-6 | Major topic |
| Serum Amyloid A Protein | Major topic |
| Microorganisms, Genetically-Modified | Major topic |
| Humans | |
| Interleukin-6 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2019-2024 | Shinshu University | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31992476 | A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. | Bioorg Med Chem | 2020 | https://conductscience.org/library/papers/31992476 | PubMed |
| 2 | 12461182 | Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12461182 | PubMed |
| 3 | 23532539 | The role of intratumoral and systemic IL-6 in breast cancer. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23532539 | PubMed |
| 4 | 24057813 | The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review. | J Mol Med (Berl) | 2013 | https://conductscience.org/library/papers/24057813 | PubMed |
| 5 | 25931255 | Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels. | Pancreas | 2015 | https://conductscience.org/library/papers/25931255 | PubMed |
| 6 | 23034889 | Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. | Int J Cancer | 2013 | https://conductscience.org/library/papers/23034889 | PubMed |
| 7 | 24015240 | Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases. | PLoS One | 2013 | https://conductscience.org/library/papers/24015240 | PubMed |
| 8 | 11237555 | Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. | Clin Immunol | 2001 | https://conductscience.org/library/papers/11237555 | PubMed |
| 9 | 15124018 | IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15124018 | PubMed |
| 10 | 12220549 | IL-6 in autoimmune disease and chronic inflammatory proliferative disease. | Cytokine Growth Factor Rev | 2002 | https://conductscience.org/library/papers/12220549 | PubMed |
| 11 | 17432959 | CD40 promotion of amyloid beta production occurs via the NF-kappaB pathway. | Eur J Neurosci | 2007 | https://conductscience.org/library/papers/17432959 | PubMed |
| 12 | 24297381 | Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial. | Ann Rheum Dis | 2014 | https://conductscience.org/library/papers/24297381 | PubMed |
| 13 | 29094311 | Tocilizumab: A Review in Rheumatoid Arthritis. | Drugs | 2017 | https://conductscience.org/library/papers/29094311 | PubMed |
| 14 | 29925278 | Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018. | Expert Rev Clin Immunol | 2018 | https://conductscience.org/library/papers/29925278 | PubMed |
| 15 | 37260086 | Interleukin-6 blocking agents for treating COVID-19: a living systematic review. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37260086 | PubMed |
| 16 | 26394632 | Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease. | BioDrugs | 2015 | https://conductscience.org/library/papers/26394632 | PubMed |
| 17 | 22474489 | scFv antibody: principles and clinical application. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22474489 | PubMed |
| 18 | 23026637 | Fusion protein linkers: property, design and functionality. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/23026637 | PubMed |
| 19 | 9973838 | Pharmacokinetics and biodistribution of genetically-engineered antibodies. | Q J Nucl Med | 1998 | https://conductscience.org/library/papers/9973838 | PubMed |
| 20 | 17957110 | Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. | J Mol Microbiol Biotechnol | 2008 | https://conductscience.org/library/papers/17957110 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003755
GET https://conductscience.org/api/papers/v1/41003755/references?page=2